|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Arbuthnot P and Kew M: Hepatitis B virus
and hepatocellular carcinoma. Int J Exp Pathol. 82:77–100. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oka H, Tamori A, Kuroki T, Kobayashi K and
Yamamoto S: Prospective study of alpha-fetoprotein in cirrhotic
patients monitored for development of hepatocellular carcinoma.
Hepatology. 19:61–66. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marrero JA and Lok AS: Newer markers for
hepatocellular carcinoma. Gastroenterology. 127:S113–S119. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mott JL: MicroRNAs involved in tumor
suppressor and oncogene pathways: implications for hepatobiliary
neoplasia. Hepatology. 50:630–637. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Visone R, Petrocca F and Croce CM:
Micro-RNAs in gastrointestinal and liver disease. Gastroenterology.
135:1866–1869. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang J, Gusev Y, Aderca I, Mettler TA,
Nagorney DM, Brackett DJ, et al: Association of MicroRNA expression
in hepatocellular carcinomas with hepatitis infection, cirrhosis,
and patient survival. Clin Cancer Res. 14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fornari F, Gramantieri L, Ferracin M,
Veronese A, Sabbioni S, Calin GA, et al: miR-221 controls
CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular
carcinoma. Oncogene. 27:5651–5661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gramantieri L, Fornari F, Callegari E,
Sabbioni S, Lanza G, Croce CM, et al: MicroRNA involvement in
hepatocellular carcinoma. J Cell Mol Med. 12:2189–2204. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cortez MA and Calin GA: MicroRNA
identification in plasma and serum: a new tool to diagnose and
monitor diseases. Expert Opin Biol Ther. 9:703–711. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, et al: Circulating microRNAs as
stable blood-based markers for cancer detection. Proc Natl Acad Sci
USA. 105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu W, Qin W, Atasoy U and Sauter ER:
Circulating microRNAs in breast cancer and healthy subjects. BMC
Res Notes. 2:892009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pain SJ, Barber RW, Ballinger JR, Solanki
CK, Mortimer PS, Purushotham AD and Peters AM: Local vascular
access of radioprotein injected subcutaneously in healthy subjects
and patients with breast cancer-related lymphedema. J Nucl Med.
45:789–796. 2004.
|
|
18
|
Croci S, Pedrazzi G, Passeri G, Delsignore
R and Ortalli I: Red cell Hb oxidation of healthy subjects compared
to breast cancer patients. Anticancer Res. 22:2903–2906.
2002.PubMed/NCBI
|
|
19
|
Würz H, Lüben G and Bohn H: Serum levels
of placental protein 10 (PP10) in women with breast cancer and
genital carcinoma and in healthy male and female subjects. Arch
Gynecol. 233:267–274. 1983.PubMed/NCBI
|
|
20
|
Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X
and Wu Z: miR-101 is down-regulated by the hepatitis B virus x
protein and induces aberrant DNA methylation by targeting DNA
methyltransferase 3A. Cell Signal. 25:439–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zinkin NT, Grall F, Bhaskar K, Otu HH,
Spentzos D, Kalmowitz B, et al: Serum proteomics and biomarkers in
hepatocellular carcinoma and chronic liver disease. Clin Cancer
Res. 14:470–477. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, et al: The microRNA spectrum in 12 body fluids.
Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, et al: Differential expression of microRNAs in plasma of
patients with colorectal cancer: a potential marker for colorectal
cancer screening. Gut. 58:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ji X, Takahashi R, Hiura Y, Hirokawa G,
Fukushima Y and Iwai N: Plasma miR-208 as a biomarker of myocardial
injury. Clin Chem. 55:1944–1949. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang K, Zhang S, Marzolf B, Troisch P,
Brightman A, Hu Z, et al: Circulating microRNAs, potential
biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA.
106:4402–4407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bianchi F, Nicassio F, Marzi M, Belloni E,
Dall’olio V, Bernard L, et al: A serum circulating miRNA diagnostic
test to identify asymptomatic high-risk individuals with early
stage lung cancer. EMBO Mol Med. 3:495–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, et al: MicroRNA profiling in
hepatocellular tumors is associated with clinical features and
oncogene/tumor suppressor gene mutations. Hepatology. 47:1955–1963.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu S, Guo W, Shi J, Li N, Yu X, Xue J, et
al: MicroRNA-135a contributes to the development of portal vein
tumor thrombus by promoting metastasis in hepatocellular carcinoma.
J Hepatol. 56:389–396. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qi P, Cheng SQ, Wang H, Li N, Chen YF and
Gao CF: Serum microRNAs as biomarkers for hepatocellular carcinoma
in Chinese patients with chronic hepatitis B virus infection. PLoS
One. 6:e284862011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brase JC, Wuttig D, Kuner R and Sültmann
H: Serum microRNAs as non-invasive biomarkers for cancer. Mol
Cancer. 9:306 View Article : Google Scholar : 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wittmann J and Jäck HM: Serum microRNAs as
powerful cancer biomarkers. Biochim Biophys Acta. 1806:200–207.
2010.PubMed/NCBI
|
|
32
|
Jackson DB: Serum-based microRNAs: are we
blinded by potential? Proc Natl Acad Sci USA. 106:E52009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qu KZ, Zhang K, Li H, Afdhal NH and
Albitar M: Circulating microRNAs as biomarkers for hepatocellular
carcinoma. J Clin Gastroenterol. 45:355–360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Skog J, Würdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, et al: Glioblastoma microvesicles
transport RNA and proteins that promote tumour growth and provide
diagnostic biomarkers. Nat Cell Biol. 10:1470–1476. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cortez MA and Calin GA: MicroRNA
identification in plasma and serum: a new tool to diagnose and
monitor diseases. Expert Opin Biol Ther. 9:703–711. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pegtel DM, Cosmopoulos K, Thorley-Lawson
DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, et
al: Functional delivery of viral miRNAs via exosomes. Proc Natl
Acad Sci USA. 107:6328–6333. 2010. View Article : Google Scholar : PubMed/NCBI
|
